Search results
-
Dr Julian Sale
... to monitor the molecular choreography of proteins and DNA at sites of stalled replication. ...
-
Professor Duncan Jodrell
I endeavour to integrate and optimise the pre-clinical development and science-led clinical application of novel therapies and novel therapeutic combinations, including first into man (phase I) and associated studies. My research goal is to identify...
-
Dr K Gatley
... 170 patients being recruited from UK participating sites. ...
-
Professor Ming-Qing Du
... B or T lymphocytes and occur at both nodal and extranodal sites. The accurate diagnosis of various lymphoma subtypes is critical in ...
-
Dr Richard Baird
Early phase clinical trials, including expertise in: ...
-
Miss Rachel Matthews
... to extract a small number of cells from multiple tumour sites; this sampling method provides a better capture of the cell populations ...
-
Dr Daniel Hodson
... cells or memory B cells, whereas less competitive B cells default to apoptosis. Rapidly changing, but tightly controlled, programmes of ...
-
Professor Jean Abraham
-
-
Dr Oscar M Rueda
Development of statistical methods and models for the analysis and integration of breast cancer high-throughput data: detection of alterations in DNA copy number and their influence in mRNA expression and survival, in order to obtain predictive markers....
-
Dr Robin Hesketh
I am based in the Biochemistry Department and work on several cancer related projects, primarily in collaboration with Jim Metcalfe, Kevin Brindle and Doug Easton. These fall into four areas (1) Development of anti-angiogenic gene therapy, (2) Studies...
-
Professor Andrea Brand
-
Dr Alison Schuldt
-
Dr Anna-Maria Shiarli
-
Mr Adam Palmer
-
Dr Avgi Andreou
-
Dr Ali Amin Al Olama
My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...
-
Mr Arqum Anwar
Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...
-
Dr Alexander Azizi
-
Miss Ariella Stewart
-
Dr Ashwin Seshia
One of the research thrusts in my group is the development of microelectromechanical and microfluidics based platforms for early diagnosis. We also research microfabricated biophysical tools to characterise biological systems at the molecular, cellular...
-
Dr Andreas Bender
... large amounts of chemical or biological data related to cancer drug discovery you are very welcome to contact me to see in which way I ...
-
Dr Alejandra Bruna
... aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in ... of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the molecular heterogeneity present in primary ...
-
Professor Antonis Antoniou
... component; - the identification and characterisation of cancer risks for genetically susceptible individuals, such as those carrying ...
-
Dr Catherine Lindon
... to coordinated cell division, and have well documented cancer-promoting activities. Ongoing projects in the lab explore how ... in time and space, and how their activity contributes to cancer. We have recently described a 'ubiquitome' of cellular components ...
-
Dr Alison Dunning
Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput ... (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response. In this we collaborate closely ... consortia for breast, ovarian, endometrial and prostate cancer association studies: BCAC http://bcac.ccge.medschl.cam.ac.uk, CIMBA ...
-
Dr Ashray Gunjur
... broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David ... between gut microbiota and outcomes in patients with rare cancer types. ...
-
Dr Ahsan MEMON
... this holographic system was deployed to the study of cancer and stem cell shape regulation and the role of effective membrane ...
-
Dr Aisling Redmond
... She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), ...
-
Professor Alan Warren
... how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome, containing ... it is also important for oncogenesis: a novel class of human cancer predisposition disorder has recently emerged that is caused by mutations ...
-
Dr John Suckling
... that the spatial distribution of brain tumours is largely explained by brain regions that are the connections between networks that are ...
-
Professor Vincent Gnanapragasam
Vincent J Gnanapragasam holds a personal Chair in Urology at the University of Cambridge and is an Honorary Consultant Urologist at Addenbrooke’s Hospital, Cambridge. He graduated from Newcastle University and following basic surgical training, was...